Skip to main content
Intended for healthcare professionals
Restricted access
Research article
First published online January 21, 2026

Distribution of Biosafety Violations in Laboratories: Implications for Measuring Biosafety Culture

Abstract

Introduction:

Effectively managing biological risk in a research setting requires a strong organizational commitment to promoting safe practices and adhering to established protocols, a concept known as a “culture of biosafety.” Although a sound culture of biosafety is critical for responsible conduct of research, its assessment remains challenging, relying on self-reporting and qualitative and subjective evaluations.

Methods:

To determine if a laboratory’s culture of biosafety could be evaluated objectively, we examined historical biosafety violation data at three U.S. universities, including biosafety cabinet recertification violations at one university and a range of violations at two other universities. These data were analyzed to determine the distribution of violations among investigators.

Results:

At all three institutions, we found that a majority of investigators operate laboratories with low rates of biosafety violations and few repeat violations; however, a minority of investigators operate laboratories that are repeatedly in violation of established biosafety guidelines and standards. Repeat violations were unequally distributed amongst laboratories, with only 20% of laboratories accounting for 70–90% of total repeat violations.

Discussion:

We found that a vast majority of investigators operate laboratories with commendable cultures of biosafety that manifest as low rates of violations and repeat violations.

Conclusion:

This research establishes metrics for evaluating a laboratory’s culture of biosafety with an objective evidence basis and transparent approach, laying the foundation for future research to understand the drivers of biosafety culture, create interventions to improve biosafety culture, and creating a near-term mechanism to promote biosafety culture at institutions via data-driven retention and recruitment strategies.

Get full access to this article

View all access and purchase options for this article.

References

1. Perkins D, Danskin K, Rowe AE, et al. The culture of biosafety, biosecurity, and responsible conduct in the life sciences: A comprehensive literature review. Appl Biosaf, 2019; 24(1):34–45;
2. Trump BD, Galaitsi SE, Appleton E, et al. Building biosecurity for synthetic biology. Mol Syst Biol, 2020; 16(7):e9723;
3. Franz DR. The role of leaders in laboratory safety: With an example from industry. Biosaf Health, 2019; 1(1):4–5;
4. Mumford MD, Steele L, Watts LL. Evaluating ethics education programs: A multilevel approach. Ethics Behav, 2015; 25(1):37–60;
5. Crain AL, Martinson BC, Thrush CR. Relationships between the Survey of Organizational Research Climate (SORC) and self-reported research practices. Sci Eng Ethics, 2013; 19(3):835–850;
6. Eeckelaert L, Starren A, van Scheppingen A, Fox D, Bruck C. Occupational safety and health culture assessment—Areview of main approaches and selected tools. (Taylor TN., ed.) European Agency for Safety and Health at Work (EU-OSHA): Luxembourg; 2011;
7. International Working Group on Strengthening the Culture of Culture of Biosafety, Biosecurity, and Responsible Conduct in the Life Sciences. Culture of Biosafety, Biosecurity, and Responsible Conduct in the Life Sciences—(Self) Assessment Framework. International Working Group on Strengthening the Culture of Culture of Biosafety, Biosecurity, and Responsible Conduct in the Life Sciences; 2020. Available from: https://absa.org/wp-content/uploads/2020/02/Culture_of_Biosafety-Biosecurity_Self-Assessment_Framework.pdf
8. National Institutes of Health (NIH). NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines). NIH; 2019. Available from: https://osp.od.nih.gov/wp-content/uploads/NIH_Guidelines.pdf
9. Haley C. Explaining the 80-20 Rule with the Pareto Distribution. UC Berkeley D-Lab; 2022. Available from: https://dlab.berkeley.edu/news/explaining-80-20-rule-pareto-distribution
10. Greene D, Palmer MJ, Relman DA. Motivating proactive biorisk management. Health Secur, 2023; 21(1):46–60;
11. Gryphon Scientific. Risk and benefit analysis of gain of function research. Gryphon Scientific; 2016. Available from: https://gryphonsci.wpengine.com/wp-content/uploads/2018/12/Risk-and-Benefit-Analysis-of-Gain-of-Function-Research-Final-Report-1.pdf

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.